O	O	0	7	Octamer	Octamer	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	8	15	binding	binding	I-NP	NN	I-protein	3	NMOD	I-protein
O	O	16	23	factors	factor	I-NP	NNS	I-protein	6	NMOD	I-protein
O	O	24	27	and	and	O	CC	O	6	NMOD	O
O	O	28	33	their	their	B-NP	PRP$	O	6	NMOD	O
O	O	34	45	coactivator	coactivator	I-NP	NN	B-protein	7	SUB	B-protein
O	O	46	49	can	can	B-VP	MD	O	0	ROOT	O
O	O	50	58	activate	activate	I-VP	VB	O	7	VC	O
O	O	59	62	the	the	B-NP	DT	O	11	NMOD	O
O	O	63	69	murine	murine	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T1	B-Protein	70	72	PU	PU	I-NP	NN	I-DNA	8	OBJ	I-DNA
T1	I-Protein	72	73	.	.	O	.	I-DNA	7	P	I-DNA
T1	I-Protein	73	74	1	1	B-NP	CD	I-DNA	19	NMOD	I-DNA
O	O	75	76	(	(	O	(	I-DNA	19	NMOD	I-DNA
T2	B-Protein	76	79	spi	spi	B-NP	NN	I-DNA	19	NMOD	I-DNA
T2	I-Protein	79	80	-	-	O	HYPH	I-DNA	17	P	I-DNA
T2	I-Protein	80	81	1	1	O	CD	I-DNA	19	NMOD	I-DNA
O	O	81	82	)	)	O	)	I-DNA	19	NMOD	I-DNA
T20	B-Entity	83	91	promoter	promoter	B-NP	NN	I-DNA	7	VMOD	I-DNA
O	O	91	92	.	.	O	.	O	7	P	O

T3	B-Protein	94	96	PU	PU	B-NP	NN	B-protein	11	NMOD	B-protein
T3	I-Protein	96	97	.	.	I-NP	.	I-protein	1	P	I-protein
T3	I-Protein	97	98	1	1	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	99	100	(	(	O	(	O	8	DEP	O
T4	B-Protein	100	103	spi	spi	B-NP	NN	B-protein	6	NMOD	B-protein
T4	I-Protein	103	104	-	-	B-NP	HYPH	I-protein	8	DEP	I-protein
T4	I-Protein	104	105	1	1	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	105	106	)	)	O	)	O	1	NMOD	O
O	O	106	107	,	,	O	,	O	11	P	O
O	O	108	109	a	a	B-NP	DT	O	11	NMOD	O
O	O	110	116	member	member	I-NP	NN	O	19	SUB	O
O	O	117	119	of	of	B-PP	IN	O	11	NMOD	O
O	O	120	123	the	the	B-NP	DT	O	17	NMOD	O
O	O	124	127	Ets	Ets	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	128	141	transcription	transcription	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	142	148	factor	factor	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	149	155	family	family	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	155	156	,	,	O	,	O	11	P	O
O	O	157	159	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	160	173	predominantly	predominantly	I-VP	RB	O	19	VMOD	O
O	O	174	183	expressed	express	I-VP	VBN	O	19	VC	O
O	O	184	186	in	in	B-PP	IN	O	21	VMOD	O
O	O	187	194	myeloid	myeloid	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	195	198	and	and	I-NP	CC	I-cell_type	26	NMOD	I-cell_type
O	O	199	200	B	B	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	201	206	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	206	207	,	,	O	,	O	19	P	O
O	O	208	217	activates	activate	B-VP	VBZ	O	19	VMOD	O
O	O	218	222	many	many	B-NP	JJ	O	28	OBJ	O
O	O	223	224	B	B	I-NP	NN	B-DNA	31	NMOD	B-DNA
O	O	225	229	cell	cell	I-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	230	233	and	and	O	CC	I-DNA	29	NMOD	I-DNA
O	O	234	241	myeloid	myeloid	B-NP	JJ	I-DNA	29	NMOD	I-DNA
T21	B-Entity	242	247	genes	gene	I-NP	NNS	I-DNA	29	NMOD	I-DNA
O	O	247	248	,	,	O	,	O	19	P	O
O	O	249	252	and	and	O	CC	O	19	VMOD	O
O	O	253	255	is	be	B-VP	VBZ	O	19	VMOD	O
O	O	256	264	critical	critical	B-ADJP	JJ	O	37	PRD	O
O	O	265	268	for	for	B-PP	IN	O	38	AMOD	O
O	O	269	280	development	development	B-NP	NN	O	39	PMOD	O
O	O	281	283	of	of	B-PP	IN	O	40	NMOD	O
O	O	284	288	both	both	B-NP	DT	O	41	PMOD	O
O	O	289	291	of	of	B-PP	IN	O	42	NMOD	O
O	O	292	297	these	these	B-NP	DT	O	45	NMOD	O
O	O	298	306	lineages	lineage	I-NP	NNS	O	43	PMOD	O
O	O	306	307	.	.	O	.	O	19	P	O

O	O	308	311	Our	Our	B-NP	PRP$	O	3	NMOD	O
O	O	312	320	previous	previous	I-NP	JJ	O	3	NMOD	O
O	O	321	328	studies	study	I-NP	NNS	O	70	SUB	O
O	O	329	330	(	(	O	(	O	69	DEP	O
O	O	330	334	Chen	Chen	B-NP	NNP	O	7	NMOD	O
O	O	334	335	,	,	O	,	O	7	P	O
O	O	336	337	H	H	B-NP	NNP	O	21	NMOD	O
O	O	337	338	.	.	B-VP	VBD	O	7	SBAR	O
O	O	338	339	M	M	B-NP	NNP	O	8	OBJ	O
O	O	339	340	.	.	O	.	O	7	P	O
O	O	340	341	,	,	O	,	O	21	P	O
O	O	342	345	Ray	Ray	B-NP	NNP	O	14	NMOD	O
O	O	345	346	-	-	I-NP	HYPH	O	14	P	O
O	O	346	352	Gallet	Gallet	I-NP	NNP	O	21	NMOD	O
O	O	352	353	,	,	O	,	O	21	P	O
O	O	354	355	D	D	B-NP	NNP	O	21	NMOD	O
O	O	355	356	.	.	O	.	O	16	P	O
O	O	356	357	,	,	O	,	O	21	P	O
O	O	358	363	Zhang	Zhang	B-NP	NN	O	21	NMOD	O
O	O	363	364	,	,	O	,	O	21	P	O
O	O	365	366	P	P	B-NP	NN	O	59	NMOD	O
O	O	366	367	.	.	O	.	O	21	P	O
O	O	367	368	,	,	O	,	O	59	P	O
O	O	369	381	Hetherington	Hetherington	B-NP	NNP	O	26	NMOD	O
O	O	381	382	,	,	O	,	O	26	P	O
O	O	383	384	C	C	B-NP	NNP	O	28	NMOD	O
O	O	384	385	.	.	I-NP	.	O	28	P	O
O	O	385	386	J	J	I-NP	NNP	O	59	NMOD	O
O	O	386	387	.	.	O	.	O	59	P	O
O	O	387	388	,	,	O	,	O	59	P	O
O	O	389	397	Gonzalez	Gonzalez	B-NP	NNP	O	33	NMOD	O
O	O	397	398	,	,	O	,	O	33	P	O
O	O	399	400	D	D	B-NP	NNP	O	35	NMOD	O
O	O	400	401	.	.	I-NP	.	O	35	P	O
O	O	401	402	A	A	I-NP	NNP	O	44	NMOD	O
O	O	402	403	.	.	O	.	O	35	P	O
O	O	403	404	,	,	O	,	O	44	P	O
O	O	405	410	Zhang	Zhang	B-NP	NNP	O	40	NMOD	O
O	O	410	411	,	,	O	,	O	40	P	O
O	O	412	413	D	D	B-NP	NNP	O	44	NMOD	O
O	O	413	414	.	.	I-NP	.	O	40	P	O
O	O	414	415	-	-	I-NP	HYPH	O	44	NMOD	O
O	O	415	416	E	E	I-NP	NN	O	44	NMOD	O
O	O	416	417	.	.	I-NP	NN	O	59	NMOD	O
O	O	417	418	,	,	O	,	O	59	P	O
O	O	419	425	Moreau	Moreau	B-NP	NNP	O	48	NMOD	O
O	O	425	426	-	-	I-NP	HYPH	O	48	P	O
O	O	426	434	Gachelin	Gachelin	I-NP	NNP	O	59	NMOD	O
O	O	434	435	,	,	O	,	O	59	P	O
O	O	436	437	F	F	B-NP	NNP	O	51	NMOD	O
O	O	437	438	.	.	I-NP	NN	O	59	NMOD	O
O	O	438	439	,	,	O	,	O	59	P	O
O	O	440	443	and	and	O	CC	O	59	NMOD	O
O	O	444	449	Tenen	Tenen	B-NP	NNP	O	59	NMOD	O
O	O	449	450	,	,	O	,	O	59	P	O
O	O	451	452	D	D	B-NP	NNP	O	59	NMOD	O
O	O	452	453	.	.	I-NP	.	O	59	P	O
O	O	453	454	G	G	I-NP	NNP	O	59	NMOD	O
O	O	454	455	.	.	I-NP	NNP	O	68	NMOD	O
O	O	455	456	(	(	O	(	O	62	DEP	O
O	O	456	460	1995	1995	B-NP	CD	O	62	DEP	O
O	O	460	461	)	)	O	)	O	68	NMOD	O
O	O	462	470	Oncogene	Oncogene	B-NP	NNP	O	68	NMOD	O
O	O	471	473	11	11	I-NP	CD	O	63	NMOD	O
O	O	473	474	,	,	I-NP	,	O	68	P	O
O	O	475	479	1549	1549	I-NP	CD	O	68	NMOD	O
O	O	479	480	-	-	I-NP	HYPH	O	68	P	O
O	O	480	484	1560	1560	I-NP	CD	O	69	DEP	O
O	O	484	485	)	)	O	)	O	3	NMOD	O
O	O	486	497	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	498	502	that	that	B-SBAR	IN	O	91	DEP	O
O	O	503	506	the	the	B-NP	DT	O	76	NMOD	O
T5	B-Protein	507	509	PU	PU	I-NP	NNP	B-DNA	76	NMOD	B-DNA
T5	I-Protein	509	510	.	.	I-NP	.	I-DNA	76	NMOD	I-DNA
T5	I-Protein	510	511	1	1	I-NP	CD	I-DNA	76	NMOD	I-DNA
T22	B-Entity	512	520	promoter	promoter	I-NP	NN	I-DNA	77	SUB	I-DNA
O	O	521	528	directs	direct	B-VP	VBZ	O	71	SBAR	O
T23	B-Entity	529	533	cell	cell	B-NP	NN	O	79	NMOD	O
T23	I-Entity	534	538	type	type	I-NP	NN	O	84	NMOD	O
T23	I-Entity	538	539	-	-	B-NP	HYPH	O	84	NMOD	O
T23	I-Entity	539	547	specific	specific	I-NP	JJ	O	84	NMOD	O
T23	I-Entity	548	556	reporter	reporter	I-NP	NN	B-DNA	84	NMOD	B-DNA
T23	I-Entity	557	561	gene	gene	I-NP	NN	I-DNA	84	NMOD	I-DNA
O	O	562	572	expression	expression	I-NP	NN	O	77	OBJ	O
O	O	573	575	in	in	B-PP	IN	O	77	VMOD	O
O	O	576	583	myeloid	myeloid	B-NP	JJ	B-cell_line	88	NMOD	B-cell_line
O	O	584	588	cell	cell	I-NP	NN	I-cell_line	88	NMOD	I-cell_line
O	O	589	594	lines	line	I-NP	NNS	I-cell_line	85	PMOD	I-cell_line
O	O	594	595	,	,	O	,	O	91	P	O
O	O	596	599	and	and	O	CC	O	91	DEP	O
O	O	600	604	that	that	B-SBAR	IN	O	70	VMOD	O
T6	B-Protein	605	607	PU	PU	B-NP	NN	B-protein	95	SUB	B-protein
T6	I-Protein	607	608	.	.	O	.	I-protein	92	P	I-protein
T6	I-Protein	608	609	1	1	B-NP	CD	I-protein	92	NMOD	I-protein
O	O	610	619	activates	activate	B-VP	VBZ	O	91	SBAR	O
O	O	620	623	its	its	B-NP	PRP$	O	98	NMOD	O
O	O	624	627	own	own	I-NP	JJ	O	98	NMOD	O
O	O	628	636	promoter	promoter	I-NP	NN	O	95	OBJ	O
O	O	637	639	in	in	B-PP	IN	O	95	VMOD	O
O	O	640	642	an	an	B-NP	DT	O	102	NMOD	O
O	O	643	657	autoregulatory	autoregulatory	I-NP	JJ	O	102	NMOD	O
O	O	658	662	loop	loop	I-NP	NN	O	99	PMOD	O
O	O	662	663	.	.	O	.	O	70	P	O

O	O	664	668	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	669	671	we	we	B-NP	PRP	O	3	SUB	O
O	O	672	676	show	show	B-VP	VBP	O	0	ROOT	O
O	O	677	681	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	682	685	the	the	B-NP	DT	O	7	NMOD	O
T24	B-Entity	686	692	murine	murine	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T7,T24	B-Protein,I-Entity	693	695	PU	PU	I-NP	NN	I-DNA	11	SUB	I-DNA
T7,T24	I-Protein,I-Entity	695	696	.	.	O	.	I-DNA	10	NMOD	I-DNA
T7,T24	I-Protein,I-Entity	696	697	1	1	B-NP	CD	I-DNA	10	NMOD	I-DNA
T24,T25	I-Entity,B-Entity	698	706	promoter	promoter	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	707	709	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	710	714	also	also	B-ADVP	RB	O	11	VMOD	O
O	O	715	727	specifically	specifically	B-ADVP	RB	O	11	PRD	O
O	O	728	731	and	and	I-ADVP	CC	O	13	AMOD	O
O	O	732	738	highly	highly	B-ADJP	RB	O	13	AMOD	O
O	O	739	749	functional	functional	I-ADJP	JJ	O	13	AMOD	O
O	O	750	752	in	in	B-PP	IN	O	11	VMOD	O
O	O	753	754	B	B	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	755	759	cell	cell	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	760	765	lines	line	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	766	768	as	as	B-ADVP	RB	O	11	VMOD	O
O	O	769	773	well	well	I-ADVP	RB	O	21	AMOD	O
O	O	773	774	.	.	O	.	O	3	P	O

T8	B-Protein	775	778	Oct	Oct	B-NP	NN	B-protein	6	NMOD	B-protein
T8	I-Protein	778	779	-	-	B-NP	HYPH	I-protein	1	NMOD	I-protein
T8	I-Protein	779	780	1	1	I-NP	CD	I-protein	2	NMOD	I-protein
O	O	781	784	and	and	I-NP	CC	O	6	NMOD	O
T9	B-Protein	785	788	Oct	Oct	I-NP	NN	B-protein	6	NMOD	B-protein
T9	I-Protein	788	789	-	-	O	HYPH	I-protein	8	P	I-protein
T9	I-Protein	789	790	2	2	B-NP	CD	I-protein	6	NMOD	I-protein
O	O	791	794	can	can	B-VP	MD	O	25	VMOD	O
O	O	795	799	bind	bind	I-VP	VB	O	8	VC	O
O	O	800	812	specifically	specifically	B-ADVP	RB	O	11	PMOD	O
O	O	813	815	to	to	B-PP	TO	O	9	VMOD	O
O	O	816	817	a	a	B-NP	DT	O	13	NMOD	O
T26	B-Entity	818	822	site	site	I-NP	NN	O	11	PMOD	O
T26	I-Entity	823	825	at	at	B-PP	IN	O	13	NMOD	O
T26	I-Entity	826	830	base	base	B-NP	NN	O	16	NMOD	O
T26	I-Entity	831	835	pair	pair	I-NP	NN	O	14	PMOD	O
T26	I-Entity	836	837	-	-	B-NP	HYPH	O	13	P	O
T26	I-Entity	837	839	55	55	I-NP	CD	O	13	NMOD	O
O	O	840	842	in	in	B-ADVP	FW	O	9	VMOD	O
O	O	843	848	vitro	vitro	I-ADVP	FW	O	19	AMOD	O
O	O	848	849	,	,	O	,	O	25	P	O
O	O	850	853	and	and	O	CC	O	25	VMOD	O
O	O	854	858	this	this	B-NP	DT	O	24	NMOD	O
O	O	859	863	site	site	I-NP	NN	O	25	SUB	O
O	O	864	866	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	867	879	specifically	specifically	I-VP	RB	O	25	VMOD	O
O	O	880	889	protected	protect	I-VP	VBN	O	25	VC	O
O	O	890	892	in	in	B-PP	IN	O	27	VMOD	O
O	O	893	894	B	B	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	895	900	cells	cell	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	901	903	in	in	B-ADVP	FW	O	27	VMOD	O
O	O	904	908	vivo	vivo	I-ADVP	FW	O	31	AMOD	O
O	O	908	909	.	.	O	.	O	25	P	O

O	O	910	912	We	We	B-NP	PRP	O	3	SUB	O
O	O	913	917	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	918	929	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	930	934	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	935	938	two	two	B-NP	CD	O	7	NMOD	O
O	O	939	944	other	other	I-NP	JJ	O	7	NMOD	O
O	O	945	950	sites	site	I-NP	NNS	O	8	SUB	O
O	O	951	961	contribute	contribute	B-VP	VBP	O	4	SBAR	O
O	O	962	964	to	to	B-PP	TO	O	8	VMOD	O
O	O	965	973	promoter	promoter	B-NP	NN	O	11	NMOD	O
O	O	974	982	activity	activity	I-NP	NN	O	9	PMOD	O
O	O	983	985	in	in	B-PP	IN	O	11	NMOD	O
O	O	986	987	B	B	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	988	993	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	993	994	;	;	O	:	O	3	P	O
O	O	995	997	an	an	B-NP	DT	O	19	NMOD	O
T10	B-Protein	998	1001	Sp1	Sp1	I-NP	NN	B-DNA	19	NMOD	B-DNA
T27	B-Entity	1002	1009	binding	binding	I-NP	NN	I-DNA	19	NMOD	I-DNA
T27	I-Entity	1010	1014	site	site	I-NP	NN	I-DNA	32	NMOD	I-DNA
O	O	1015	1023	adjacent	adjacent	B-ADJP	JJ	O	19	NMOD	O
O	O	1024	1026	to	to	B-PP	TO	O	20	AMOD	O
O	O	1027	1030	the	the	B-NP	DT	O	24	NMOD	O
T28	B-Entity	1031	1038	octamer	octamer	I-NP	NN	B-DNA	24	NMOD	B-DNA
T28	I-Entity	1039	1043	site	site	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	1043	1044	,	,	O	,	O	32	P	O
O	O	1045	1048	and	and	O	CC	O	32	NMOD	O
O	O	1049	1052	the	the	B-NP	DT	O	28	NMOD	O
T11	B-Protein	1053	1055	PU	PU	I-NP	NN	B-DNA	32	NMOD	B-DNA
T11	I-Protein	1055	1056	.	.	O	.	I-DNA	32	NMOD	I-DNA
T11	I-Protein	1056	1057	1	1	B-NP	CD	I-DNA	32	NMOD	I-DNA
T29	B-Entity	1058	1072	autoregulatory	autoregulatory	I-NP	JJ	I-DNA	32	NMOD	I-DNA
T29	I-Entity	1073	1077	site	site	I-NP	NN	I-DNA	3	VMOD	I-DNA
O	O	1077	1078	.	.	O	.	O	3	P	O

O	O	1079	1086	Finally	Finally	B-ADVP	RB	O	4	VMOD	O
O	O	1086	1087	,	,	O	,	O	4	P	O
O	O	1088	1090	we	we	B-NP	PRP	O	4	SUB	O
O	O	1091	1095	show	show	B-VP	VBP	O	0	ROOT	O
O	O	1096	1100	that	that	B-SBAR	IN	O	32	DEP	O
O	O	1101	1104	the	the	B-NP	DT	O	18	NMOD	O
O	O	1105	1106	B	B	I-NP	NN	O	18	NMOD	O
O	O	1107	1111	cell	cell	I-NP	NN	O	18	NMOD	O
O	O	1112	1123	coactivator	coactivator	I-NP	NN	O	18	NMOD	O
T12	B-Protein	1124	1127	OBF	OBF	I-NP	NN	B-protein	18	NMOD	B-protein
T12	I-Protein	1127	1128	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T12	I-Protein	1128	1129	1	1	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	1129	1130	/	/	I-NP	SYM	O	18	NMOD	O
T13	B-Protein	1130	1134	Bob1	Bob1	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	1134	1135	/	/	B-NP	SYM	O	18	NMOD	O
T14	B-Protein	1135	1138	OCA	OCA	I-NP	NN	B-protein	18	NMOD	B-protein
T14	I-Protein	1138	1139	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T14	I-Protein	1139	1140	B	B	B-NP	NN	I-protein	19	SUB	I-protein
O	O	1141	1143	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	1144	1148	only	only	I-VP	RB	O	19	VMOD	O
O	O	1149	1158	expressed	express	I-VP	VBN	O	19	VC	O
O	O	1159	1161	in	in	B-PP	IN	O	21	VMOD	O
O	O	1162	1163	B	B	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1164	1169	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	1170	1173	and	and	O	CC	O	22	PMOD	O
O	O	1174	1177	not	not	B-PP	RB	O	27	PMOD	O
O	O	1178	1180	in	in	I-PP	IN	O	22	PMOD	O
O	O	1181	1188	myeloid	myeloid	B-NP	JJ	B-cell_type	29	NMOD	B-cell_type
O	O	1189	1194	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	1194	1195	,	,	O	,	O	32	P	O
O	O	1196	1199	and	and	O	CC	O	32	DEP	O
O	O	1200	1204	that	that	B-SBAR	IN	O	4	VMOD	O
T15	B-Protein	1205	1208	OBF	OBF	B-NP	NN	B-protein	41	NMOD	B-protein
T15	I-Protein	1208	1209	-	-	B-NP	HYPH	I-protein	41	NMOD	I-protein
T15	I-Protein	1209	1210	1	1	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	1210	1211	/	/	I-NP	SYM	O	41	P	O
T16	B-Protein	1211	1215	Bob1	Bob1	I-NP	NN	B-protein	41	NMOD	B-protein
O	O	1215	1216	/	/	B-NP	SYM	O	41	P	O
T17	B-Protein	1216	1219	OCA	OCA	I-NP	NN	B-protein	41	NMOD	B-protein
T17	I-Protein	1219	1220	-	-	B-NP	HYPH	I-protein	41	NMOD	I-protein
T17	I-Protein	1220	1221	B	B	I-NP	NN	I-protein	42	SUB	I-protein
O	O	1222	1225	can	can	B-VP	MD	O	32	SBAR	O
O	O	1226	1239	transactivate	transactivate	I-VP	VB	O	42	VC	O
O	O	1240	1243	the	the	B-NP	DT	O	48	NMOD	O
T18	B-Protein	1244	1246	PU	PU	I-NP	NNP	B-DNA	48	NMOD	B-DNA
T18	I-Protein	1246	1247	.	.	I-NP	.	I-DNA	45	P	I-DNA
T18	I-Protein	1247	1248	1	1	I-NP	CD	I-DNA	48	NMOD	I-DNA
T30	B-Entity	1249	1257	promoter	promoter	I-NP	NN	I-DNA	43	OBJ	I-DNA
O	O	1258	1260	in	in	B-PP	IN	O	43	VMOD	O
O	O	1261	1265	HeLa	HeLa	B-NP	NN	B-cell_line	53	NMOD	B-cell_line
O	O	1266	1269	and	and	O	CC	O	53	NMOD	O
O	O	1270	1277	myeloid	myeloid	B-NP	JJ	B-cell_type	53	NMOD	B-cell_type
O	O	1278	1283	cells	cell	I-NP	NNS	I-cell_type	49	PMOD	I-cell_type
O	O	1283	1284	.	.	O	.	O	4	P	O

O	O	1285	1289	This	This	B-NP	DT	O	5	NMOD	O
O	O	1290	1291	B	B	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	1292	1296	cell	cell	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	1297	1307	restricted	restricted	I-NP	JJ	I-protein	5	NMOD	I-protein
O	O	1308	1319	coactivator	coactivator	I-NP	NN	I-protein	6	SUB	I-protein
O	O	1320	1323	may	may	B-VP	MD	O	0	ROOT	O
O	O	1324	1326	be	be	I-VP	VB	O	6	VC	O
O	O	1327	1338	responsible	responsible	B-ADJP	JJ	O	7	PRD	O
O	O	1339	1342	for	for	B-PP	IN	O	8	AMOD	O
O	O	1343	1346	the	the	B-NP	DT	O	14	NMOD	O
O	O	1347	1348	B	B	I-NP	NN	O	14	NMOD	O
O	O	1349	1353	cell	cell	I-NP	NN	O	14	NMOD	O
O	O	1354	1362	specific	specific	I-NP	JJ	O	14	NMOD	O
O	O	1363	1373	expression	expression	I-NP	NN	O	9	PMOD	O
O	O	1374	1376	of	of	B-PP	IN	O	14	NMOD	O
T19	B-Protein	1377	1379	PU	PU	B-NP	NN	B-protein	15	PMOD	B-protein
T19	I-Protein	1379	1380	.	.	O	.	I-protein	16	P	I-protein
T19	I-Protein	1380	1381	1	1	B-NP	CD	I-protein	16	NMOD	I-protein
O	O	1382	1390	mediated	mediate	B-VP	VBN	O	16	NMOD	O
O	O	1391	1393	by	by	B-PP	IN	O	19	VMOD	O
O	O	1394	1397	the	the	B-NP	DT	O	23	NMOD	O
T31	B-Entity	1398	1405	octamer	octamer	I-NP	NN	B-DNA	23	NMOD	B-DNA
T31	I-Entity	1406	1410	site	site	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	1410	1411	.	.	O	.	O	6	P	O
